Collagen Family and Other Matrix Remodeling Proteins Identified by Bioinformatics Analysis as Hub Genes Involved in Gastric Cancer Progression and Prognosis
Open accessThe DOI matches its Crossref record; 72 of the 76 references it cites were found in a registry or an index.
Abstract
Gastric cancer has remained in the top five cancers for over ten years, both in terms of incidence and mortality due to the shortage of biomarkers for disease follow-up and effective therapies. Aiming to fill this gap, we performed a bioinformatics assessment on our data and two additional GEO microarray profiles, followed by a deep analysis of the 40 differentially expressed genes identified. PPI network analysis and MCODE plug-in pointed out nine upregulated hub genes coding for proteins from the collagen family (COL12A1, COL5A2, and COL10A1) or involved in the assembly (BGN) or degradation of collagens (CTHRC1), and also associated with cell adhesion (THBS2 and SPP1) and extracellular matrix degradation (FAP, SULF1). Those genes were highly upregulated at the mRNA and protein level, the increase being correlated with pathological T stages. The high expression of BGN (p = 8 × 10−12), THBS2 (p = 1.2 × 10−6), CTHRC1 (p = 1.1 × 10−4), SULF1 (p = 3.8 × 10−4), COL5A1 (p = 1.3 × 10−4), COL10A1 (p = 5.7 × 10−4), COL12A1 (p = 2 × 10−3) correlated with poor overall survival and an immune infiltrate based especially on immunosuppressive M2 macrophages (p-value range 4.82 × 10−7–1.63 × 10−13). Our results emphasize that these genes could be candidate biomarkers for GC progression and prognosis and new therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ao, R., Guan, L., Wang, Y., & Wang, J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26524 · Cited by 151 · cited 1×
“An increased expression of THBS2 seems to sustain cancer progression in GC [47] and is associated with a poor prognosis in colorectal cancer [48].”
BackgroundRetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“According to GLOBOCAN 2020’s latest data, gastric cancer (GC) is the fifth most common cancer worldwide, with over 1,000,000 new cases each year, and also the fourth cause of cancer-related death in the world, with a 5-year survival rate of around 32% [1].”
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888 · cited 1×
“Then, Cytotype Molecular Complex Detection (MCODE) plug-in in Cytoscape software was used to detect hub genes in the PPI network [22].”
MethodSzklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108 · cited 1×
“2021) [20] and Kyoto Encyclopedia of Gene and Genome (KEGG).”
BackgroundNCBI GEO: archive for functional genomics data sets—update
Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., Marshall, K. A., Phillippy, K. H., Sherman, P. M., Holko, M., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1193 · Cited by 10,418 · cited 1×
“gov/geo/; access date 5 November 2021) [17], GSE13911 [18], and GSE79973 [19], including a total of 55 gastric tumor samples and 53 adjacent non-tumor tissues, were used for differential analysis.”
MethodTIMER2.0 for analysis of tumor-infiltrating immune cells
Li, T., Fu, J., Zeng, Z., Cohen, D., Li, J., Chen, Q., Li, B., & Liu, X. S. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa407 · Cited by 5,209
The extracellular matrix at a glance
Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334 · cited 1×
“Collagen family proteins, together with elastins, fibronectins, and laminins, play an important role in tissue organization as parts of the ECM, sustaining tissue resistance and its main form [27].”
BackgroundThe Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
(2011) · Hepatogastroenterology · doi:10.5754/hge11753 · Cited by 2,435
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO reports · doi:10.15252/embr.201439246 · Cited by 1,996
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515 · cited 1×
“This is due to an early programing during cancer development of cancerassociated fibroblast, via IL-1β-secretion and nuclear factor-κB (NF-κB) activation, to sustain a tumor-promoting inflammatory response [63].”
BackgroundZhu, Y., Knolhoff, B. L., Meyer, M. A., Nywening, T. M., West, B. L., Luo, J., Wang-Gillam, A., Goedegebuure, S. P., Linehan, D. C., & DeNardo, D. G. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3723 · Cited by 1,324 · cited 2×
“efficacy of anti-PD-1/PD-L1 or anti-CTLA-4 therapy [69].”
BackgroundHER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Gravalos, C., & Jimeno, A. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn169 · Cited by 1,184 · cited 1×
“HER2 positive GC was correlated with more aggressive disease and poor outcomes [7].”
BackgroundAcerbi, I., Cassereau, L., Dean, I., Shi, Q., Au, A., Park, C., Chen, Y. Y., Liphardt, J., Hwang, E. S., & Weaver, V. M. (2015) · Integrative Biology · doi:10.1039/c5ib00040h · Cited by 1,059 · cited 1×
“These findings indicate that cancer progression, collagen deposition, and matrix stiffness are linked, and implicate tissue inflammation and TGF beta [64].”
BackgroundSzász, A. M., Lánczky, A., Nagy, Á., Förster, S., Hark, K., Green, J. E., Boussioutas, A., Busuttil, R., Szabó, A., & Győrffy, B. (2016) · Oncotarget · doi:10.18632/oncotarget.10337 · Cited by 988
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.
Kieffer, Y., Hocine, H. R., Gentric, G., Pelon, F., Bernard, C., Bourachot, B., Lameiras, S., Albergante, L., Bonneau, C., Guyard, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1384 · Cited by 910 · cited 1×
“immunosuppressive proprieties for the tumor microenvironment [45].”
Kuang, D.-M., Zhao, Q., Peng, C., Xu, J., Zhang, J.-P., Wu, C., & Zheng, L. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082173 · Cited by 903 · cited 1×
“Additionally, studies have shown that M2 macrophages can directly inhibit the T cell response by expressing PD-L1 on their surface [68].”
ResultJayasingam, S. D., Citartan, M., Thang, T. H., Mat Zin, A. A., Ang, K. C., & Ch'ng, E. S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01512 · Cited by 635 · cited 1×
“M2 macrophages create an immunosuppressive microenvironment, which favors angiogenesis by directly secreting vascular epithelial growth factors (VEGFs), and various immunosuppressive molecules such as TGFb, IL-10, or immune checkpoints [57,58].”
BackgroundHER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Van Cutsem, E., Bang, Y.-J., Feng-yi, F., Xu, J. M., Lee, K.-W., Jiao, S.-C., Chong, J. L., López-Sanchez, R. I., Price, T., Gladkov, O., et al. (2015) · Gastric Cancer · doi:10.1007/s10120-014-0402-y · Cited by 608 · cited 1×
“7 months, according to the results from the ToGA trial [8].”
ResultNissen, N. I., Karsdal, M., & Willumsen, N. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1110-6 · Cited by 489
TIMPs: versatile extracellular regulators in cancer
Jackson, H. W., Defamie, V., Waterhouse, P., & Khokha, R. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.115 · Cited by 454 · cited 3×
“TIMP-1 can stimulate cell proliferation, accelerating tumor invasion and metastasis, via important signaling pathways such as NOTCH and WNT [13,14], with recent reports demonstrating the poor prognostic value of TIMP-1-positive expression in solid cancers [15].”
BackgroundThe Role of the Extracellular Matrix in Cancer Stemness
Nallanthighal, S., Heiserman, J. P., & Cheon, D.-J. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00086 · Cited by 344
Genome-wide expression profile of sporadic gastric cancers with microsatellite instability
D’Errico, M., Rinaldis, E. D., Blasi, M. F., Viti, V., Falchetti, M., Calcagnile, A., Sera, F., Saieva, C., Ottini, L., Palli, D., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.032 · Cited by 311 · cited 4×
“gov/geo/; access date 5 November 2021) [17], GSE13911 [18], and GSE79973 [19], including a total of 55 gastric tumor samples and 53 adjacent non-tumor tissues, were used for differential analysis.”
MethodInfluentialMolecular Repolarisation of Tumour-Associated Macrophages
Van Dalen, F. J., Van Stevendaal, M. H. M. E., Fennemann, F. L., Verdoes, M., & Ilina, O. (2018) · Molecules · doi:10.3390/molecules24010009 · Cited by 302 · cited 1×
“M2 macrophages create an immunosuppressive microenvironment, which favors angiogenesis by directly secreting vascular epithelial growth factors (VEGFs), and various immunosuppressive molecules such as TGFb, IL-10, or immune checkpoints [57,58].”
BackgroundMaller, O., Drain, A. P., Barrett, A. S., Borgquist, S., Ruffell, B., Zakharevich, I., Pham, T. T., Gruosso, T., Kuasne, H., Lakins, J. N., et al. (2021) · Nature Materials · doi:10.1038/s41563-020-00849-5 · Cited by 298
Herrera, M., Herrera, A., Domínguez, G., Silva, J., García, V., García, J. M., Gómez, I., Soldevilla, B., Muñoz, C., Provencio, M., et al. (2013) · Cancer Science · doi:10.1111/cas.12096 · Cited by 289 · cited 1×
“The M2 infiltrate was associated with poor prognosis in colorectal or oral squamous epithelial cells [65,66].”
BackgroundMatrix metalloproteinases in cancer invasion, metastasis and angiogenesis
Foda, H. D., & Zucker, S. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01752-4 · Cited by 262 · cited 1×
“In the meantime, tumor cells begin to secrete matrixdegrading enzymes, which in turn degrade the matrix and release cytokines and growth factors that signal cancer cells proliferation, favoring tumor growth and progression [29].”
BackgroundPylayeva, Y., Gillen, K. M., Gerald, W., Beggs, H. E., Reichardt, L. F., & Giancotti, F. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37160 · Cited by 261 · cited 1×
“There are also evidences that collagens together with fibronectin, integrin, and laminin, and other components of ECM, are directly involved in tumor initiation and progression to metastasis by engaging in the EMT program by inducing signals through focal adhesion kinase, a core component of integrin signaling, promot…”
BackgroundNazareth, M. R., Broderick, L., Simpson-Abelson, M. R., Kelleher, R. J., Yokota, S. J., & Bankert, R. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5552 · Cited by 259
Gastric cancer prevention strategies: A global perspective
Eusebi, L. H., Telese, A., Marasco, G., Bazzoli, F., & Zagari, R. M. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15037 · Cited by 252 · cited 1×
“The high rate of mortality is due to the fact that the majority of GC patients are diagnosed at late stages when treatment is often useless (about 20% of GC patients are diagnosed in early stages in Europe), and the therapeutic approach still consists only of combined chemo-radiation therapy followed by surgical resec…”
BackgroundBulle, A., & Lim, K.-H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00341-1 · Cited by 201
Fujii, N., Shomori, K., Shiomi, T., Nakabayashi, M., Takeda, C., Ryoke, K., & Ito, H. (2012) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2012.01127.x · Cited by 191 · cited 1×
“The M2 infiltrate was associated with poor prognosis in colorectal or oral squamous epithelial cells [65,66].”
BackgroundKim, K. C., Koh, Y. W., Chang, H.-M., Kim, T. H., Yook, J. H., Kim, B. S., Jang, S. J., & Park, Y. S. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1695-2 · Cited by 175 · cited 1×
“HER2 overexpression was recognized as another biomarker in GC, and its presence was documented to be associated with 12–22% of GC [5,6].”
BackgroundTumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
Jeong, H., Hwang, I., Kang, S. H., Shin, H. C., & Kwon, S. Y. (2019) · Journal of Breast Cancer · doi:10.4048/jbc.2019.22.e5 · Cited by 169 · cited 1×
“The TIMER analysis showed that upregulation of these genes was positively correlated with M2 macrophages that are associated with more aggressive tumor features, reflected by tumor progression, invasion, and metastasis [55,56].”
BackgroundThe Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progression and Metastasis
Mei, D. F., Zhu, Y., Zhang, L., & Wei, W. (2020) · Mediators of Inflammation · doi:10.1155/2020/9578701 · Cited by 133 · cited 1×
“Moreover, it is considered that CTHRC1 could promote early-stage cancer and is a candidate as a prognostic biomarker, signaling tumor recurrence or metastasis [46].”
BackgroundHur, K., Han, T., Jung, E., Yu, J., Lee, H., Kim, W. H., Goel, A., & Yang, H. (2012) · The Journal of Pathology · doi:10.1002/path.4055 · Cited by 104 · cited 1×
“SULF1 (human sulfatase 1) is overexpressed in GC [52] and the inhibition of SULF1 expression resulted in decreased proliferation, migration, and invasion in urothelial carcinomas cell lines [53].”
BackgroundPantano, F., Berti, P., Guida, F. M., Perrone, G., Vincenzi, B., Amato, M. M. C., Righi, D., Dell'Aquila, E., Graziano, F., Catalano, V., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12109 · Cited by 100 · cited 1×
“Polarization toward the M2 phenotype, reflected by low M1/M2 ratio was found to be a predictor for poor prognosis in several cancers [59,60].”
BackgroundCoto-Llerena, M., Ercan, C., Kancherla, V., Taha-Mehlitz, S., Eppenberger-Castori, S., Soysal, S. D., Ng, C. K. Y., Bolli, M., von Flüe, M., Nicolas, G. P., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00979 · Cited by 99
Hettiarachchi, S. U., Li, Y.-H., Roy, J., Zhang, F., Puchulu-Campanella, E., Lindeman, S. D., Srinivasarao, M., Tsoyi, K., Liang, X., Ayaub, E. A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay3724 · Cited by 93 · cited 1×
“The inhibitor effectively reduced collagen production, showing that collagen-producing cells could be an effective target in human lung fibrosis [70].”
BackgroundMokadem, I., Dijksterhuis, W. P. M., van Putten, M., Heuthorst, L., de Vos‐Geelen, J., Mohammad, N. H., Nieuwenhuijzen, G. A. P., van Laarhoven, H. W. M., & Verhoeven, R. H. A. (2019) · Gastric Cancer · doi:10.1007/s10120-019-00956-6 · Cited by 88 · cited 1×
“A significant percentage of GC patients develop recurrent disease represented by distant metastases, despite surgery and perioperative treatment [3].”
BackgroundHigh expression of COL10A1 is associated with poor prognosis in colorectal cancer
Huang, H., Li, T., Ye, G., Zhao, L., Zhang, Z., Mo, D., Wang, Y., Zhang, C., Deng, H., Li, G., et al. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s160196 · Cited by 83
Sun, X., Glynn, D. J., Hodson, L. J., Huo, C. W., Britt, K. L., Thompson, E. W., Woolford, L., Evdokiou, A., Pollard, J. W., Robertson, S. A., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-016-0796-z · Cited by 82 · cited 1×
“The tumor-promoting inflammatory infiltrate is recruited and activated by tumor stroma [61,62].”
BackgroundDuan, S., Gong, B., Wang, P., Huang, H., Luo, L., & Liu, F. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9368 · Cited by 81
Barros, M. H. M., Segges, P., Vera‐Lozada, G., Hassan, R., & Niedobitek, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124531 · Cited by 79 · cited 1×
“Polarization toward the M2 phenotype, reflected by low M1/M2 ratio was found to be a predictor for poor prognosis in several cancers [59,60].”
BackgroundThe Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers
Wei, T., Bi, G., Bian, Y., Ruan, S., Yuan, G., Xie, H., Zhao, M., Shen, R., Zhu, Y., Wang, Q., et al. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.565383 · Cited by 76 · cited 1×
“Secreted phosphoprotein 1 (SPP1) expression level was correlated with tumor stage and aggressiveness in several cancers, including colorectal cancer [50,51].”
BackgroundRen, X., Chen, X., Fang, K., Zhang, X., Wei, X., Zhang, T.-T., Li, G., Lü, Z., Song, N., Wang, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.583083 · Cited by 73
Klingen, T. A., Chen, Y., Aas, H., Wik, E., & Akslen, L. A. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.09.001 · Cited by 67 · cited 1×
“The TIMER analysis showed that upregulation of these genes was positively correlated with M2 macrophages that are associated with more aggressive tumor features, reflected by tumor progression, invasion, and metastasis [55,56].”
BackgroundCOL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer
Jiang, X., Wu, M., Xu, X., Zhang, L., Huang, Y., Xu, Z., He, K., Wang, H., Wang, H., & Teng, L. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10548 · Cited by 62
Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer
Zhang, M., Chen, H., Wang, M., Bai, F., & Wu, K. (2020) · Bioscience Reports · doi:10.1042/bsr20193286 · Cited by 59
Lu, X., Zhang, J., Zhang, S., Qiao, J., Qiu, M., Liu, X.-R., Chen, X., Gao, C., & Zhang, H.-H. (2021) · BMC Cancer · doi:10.1186/s12885-021-08358-7 · Cited by 56 · cited 1×
“found that SPP1 and FN1 were correlated with tumor relapse and poor prognosis [10], Liu et al.”
BackgroundJingSong, H., Hong, G., Yang, J., Duo, Z., Li, F., WeiCai, C., XueYing, L., YouSheng, M., YiWen, O., Pan, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13716 · Cited by 56
Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers
Zhao, S., Yin, X., Zhao, W., Liu, L., & Wang, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.11266 · Cited by 56 · cited 1×
“BGN was found to be secreted by tumor endothelial cells and was able to induce tumor angiogenesis and metastasis [43].”
BackgroundCOL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis
Ding, Y., Sun, S.-F., & Zhao, G.-L. (2021) · Medicine · doi:10.1097/md.0000000000024561 · Cited by 54
Tu, Y., Chen, C., & Fan, G. (2019) · BMC Cancer · doi:10.1186/s12885-019-6441-3 · Cited by 53 · cited 1×
“Secreted phosphoprotein 1 (SPP1) expression level was correlated with tumor stage and aggressiveness in several cancers, including colorectal cancer [50,51].”
BackgroundVočka, M., Langer, D., Frýba, V., Petrtýl, J., Hanuš, T., Kalousová, M., Zima, T., & Petruzelka, L. B. (2019) · The International Journal of Biological Markers · doi:10.1177/1724600819866202 · Cited by 48 · cited 1×
“TIMP-1 can stimulate cell proliferation, accelerating tumor invasion and metastasis, via important signaling pathways such as NOTCH and WNT [13,14], with recent reports demonstrating the poor prognostic value of TIMP-1-positive expression in solid cancers [15].”
BackgroundIdentification of potential biomarkers for early and advanced gastric adenocarcinoma detection.
Chivu‐Economescu, M., Necula, L. G., Dragu, D., Badea, L., Dima, S., Tudor, Ș., Năstase, A., Popescu, I., & Diaconu, C. C. (2010) · PubMed · Cited by 47
Self-citationOverexpression of HS6ST2 is associated with poor prognosis in patients with gastric cancer
Jin, Y., He, J., Du, J., Zhang, R., Yao, H., & Shao, Q. (2017) · Oncology Letters · doi:10.3892/ol.2017.6944 · Cited by 45 · cited 4×
“gov/geo/; access date 5 November 2021) [17], GSE13911 [18], and GSE79973 [19], including a total of 55 gastric tumor samples and 53 adjacent non-tumor tissues, were used for differential analysis.”
MethodInfluentialXu, C., Gu, L., Kuerbanjiang, M., Wen, S., Xu, Q. R., & Xue, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.557730 · Cited by 41 · cited 1×
“An increased expression of THBS2 seems to sustain cancer progression in GC [47] and is associated with a poor prognosis in colorectal cancer [48].”
BackgroundHigh plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients
Necula, L. G., Matei, L., Dragu, D., Pitica, I. M., Neagu, A. I., Bleoţu, C., Dima, S., Popescu, I., Diaconu, C. C., & Chivu‐Economescu, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i22.3024 · Cited by 35
Self-citationLee, H.-Y., Yeh, B., Chan, T., Yang, K.-F., Li, W., Huang, C., Ke, H., Li, C., Yeh, H., Liang, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17590 · Cited by 33 · cited 1×
“SULF1 (human sulfatase 1) is overexpressed in GC [52] and the inhibition of SULF1 expression resulted in decreased proliferation, migration, and invasion in urothelial carcinomas cell lines [53].”
BackgroundChen, Y., Chen, W., Dai, X., Zhang, C., Zhang, Q., & Lu, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106798 · Cited by 32 · cited 1×
“identified COL1A1, COL1A2, and COL12A1 as prognostic biomarkers and immune-associated targets in GC using two GEO OMBIBUS data files with 25 pairs of gastric tumor and adjacent non-tumor mucosa tissues [25].”
Udgata, S., Takenaka, N., Bamlet, W. R., Oberg, A. L., Yee, S. S., Carpenter, E. L., Herman, D. S., Kim, J., Petersen, G. M., & Zaret, K. S. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0403 · Cited by 31 · cited 1×
“Moreover, a recent study reported circulating THBS2 and CA19-9 levels as possible candidates for a panel that detects early stages of pancreatic ductal adenocarcinoma [49].”
BackgroundLi, Z., Liu, Z., Shao, Z., Li, C., Li, Y., Liu, Q., Zhang, Y., Tan, B., & Liu, Y. (2020) · PeerJ · doi:10.7717/peerj.9123 · Cited by 28 · cited 1×
“extended the list including other family members such as COL1A1, COL1A2, COL3A1, COL5A2, COL4A1, FN1, COL5A1, COL4A2, and COL6A3, where COL1A1 and COL1A2 were proposed as poor prognostic biomarkers for GC [26].”
BackgroundIdentification of Key Genes in Gastric Cancer by Bioinformatics Analysis
Chong, X., Peng, R., Sun, Y., Zhang, L., & Zhang, Z. (2020) · BioMed Research International · doi:10.1155/2020/7658230 · Cited by 28 · cited 1×
“found FN1, TIMP1, SPP1, APOE, and VCAN genes to be associated with poor overall survival in GC patients [12].”
BackgroundIdentification of potential key genes in gastric cancer using bioinformatics analysis
Wang, W., He, Y., Zhao, Q., Zhao, X., & Li, Z. (2020) · Biomedical Reports · doi:10.3892/br.2020.1281 · Cited by 24 · cited 1×
“reported FN1, COL1A1, INHBA, and CST1 to be associated with worse overall survival in GC [9], Lu et al.”
BackgroundBrodsky, A. S., Khurana, J., Guo, K. S., Wu, E. Y., Yang, D., Siddique, A., Wong, I. Y., Uzun, E. D. G., & Resnick, M. B. (2022) · BMC Cancer · doi:10.1186/s12885-021-09136-1 · Cited by 23 · cited 1×
“The results showed that the mutations were associated with a distinctive lower matrisome expression, due to the loss of collagen expression and secretion, strongly associated with improved outcomes [36].”
BackgroundClinical Applications of Liquid Biopsy in Gastric Cancer
Chivu‐Economescu, M., Necula, L. G., Matei, L., Dragu, D., Bleoţu, C., & Diaconu, C. C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.749250 · Cited by 20 · cited 1×
“Since many of the identified genes can be measured through the soluble plasma circulating proteins with available immune-enzymatic tests, these biomarkers offer a less invasive and more accessible approach to obtain real-time progression information of the tumor burden and have proved to be really helpful in estimatin…”
BackgroundSelf-citation3541 POSTER HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer
Lordick, F., Bang, Y., Kang, Y., Reyes, D. O., Manikhas, G. M., Shen, L., Kulikov, E., Stoss, O., Jordan, B. W. M., & Cutsem, E. V. (2007) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(07)71044-3 · Cited by 15 · cited 1×
“HER2 overexpression was recognized as another biomarker in GC, and its presence was documented to be associated with 12–22% of GC [5,6].”
BackgroundBioinformatic analysis of potential hub genes in gastric adenocarcinoma
Liu, H., Qu, Y., Zhou, H., Zheng, Z., Zhao, J., & Zhang, J. (2021) · Science Progress · doi:10.1177/00368504211004260 · Cited by 14 · cited 1×
“identified TIMP1, SPP1, CXCL8, THY1, and COL1A1 genes to be negatively correlated with survival [11], and Chong et al.”
BackgroundQin, L., Wang, Y., Yang, N., Zhang, Y., Zhao, T., Wu, Y., & Jiang, J. (2021) · PeerJ · doi:10.7717/peerj.10859 · Cited by 12 · cited 3×
“TIMP-1 can stimulate cell proliferation, accelerating tumor invasion and metastasis, via important signaling pathways such as NOTCH and WNT [13,14], with recent reports demonstrating the poor prognostic value of TIMP-1-positive expression in solid cancers [15].”
BackgroundGastrointestinal cancer stem cells as targets for innovative immunotherapy
Chivu‐Economescu, M., Necula, L. G., Matei, L., Dragu, D., Neagu, A. I., Alexiu, I., Bleoţu, C., & Diaconu, C. C. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i14.1580 · Cited by 12 · cited 1×
“Clinical trials combining immunotherapy, targeted therapy, and chemotherapy are in progress, and will represent a landmark in cancer management [71].”
BackgroundSelf-citation
Cited by
Collagen Family as Promising Biomarkers and Therapeutic Targets in Cancer
Necula, L. G., Matei, L., Dragu, D., Pitica, I. M., Neagu, A. I., Bleoţu, C., Diaconu, C. C., & Chivu‐Economescu, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012415 · Cited by 98
Self-citationMatsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“[19] Abbreviations: GC, gastric cancer; TCGA, The Cancer Genome Atlas; GEO, Gene Expression Omnibus; GO, gene oncology; KEGG, The Kyoto Encyclopedia of Genes and Genomes; WGCNA, weighted correlation network analysis; TIMER, Tumor Immune Estimation Resource; PPI, protein–protein interaction; N.A.,…”
BackgroundXie, W., Cheng, J. R., Hong, Z., Cai, W., Zhuo, H., Hou, J., Lin, L., Wei, X., Wang, K., Chen, X., et al. (2022) · Cancers · doi:10.3390/cancers15010164 · Cited by 55
“Regarding GC, however, the prognostic value of SPP1 remains controversial [15,16].”
BackgroundHong, J., Du, K., Jin, H., Chen, Y., Jiang, Y., Zhang, W., Chen, D., Zheng, S., & Cao, L. (2024) · Environment International · doi:10.1016/j.envint.2024.108582 · Cited by 47
The Multifaced Role of Collagen in Cancer Development and Progression
Buglio, G. L., Cicero, A. L., Campora, S., & Ghersi, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413523 · Cited by 42
Metadata
- Authors
- Chivu-Economescu, M., Necula, L. G., Matei, L., Dragu, D., Bleotu, C., Sorop, A., Herlea, V., Dima, S., Popescu, I., & Diaconu, C. C.
- Affiliations
- Department of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, 030304 Bucharest, Romania
- Titu Maiorescu University (RO)
- Romanian Academy (RO)
- Institutul Clinic Fundeni (RO)
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-03-16
- Volume
- 23
- Issue
- 6
- Pages
- 3214
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8950589
- OpenAlex
- W4221033296
- Cited by
- 42
- References
- 76
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 11 · 2023: 18 · 2022: 3
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii (PN-III-P4-ID-PCCF-2016-0158, PN-III-P1-1.1-TE-2019-1864)
- Topics
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- gastric cancer, hub genes, extracellular matrix remodeling, COL12A1, COL5A2, COL10A1, BGN, CTHRC1, thrombospondin-2, osteopontin, SULF1, FAP, M2 macrophages, tumor immune infiltration, prognostic factors, tumor progression, T stage, overall survival
- MeSH terms
- Collagen, Humans, RNA, Messenger, Stomach Neoplasms, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Extracellular Matrix Proteins, Computational Biology, Gene Expression Profiling, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.